The healthcare industry’s response to the COVID-19 pandemic would likely have benefitted from fully interoperable systems, particularly regarding contact tracing and the integration of public health data with clinical care. In a recent panel discussion with Healthcare IT Today, Cotiviti CEO Emad Rizk, M.D., discussed how the pandemic has shaped the conversation around interoperability and the opportunities that lie ahead. Watch the video here on the Cotiviti blog.
View the panel discussion as Dr. Rizk explains:
- The benefits of interoperability in a pandemic response, including isolating high-risk populations more quickly
- The implications of the 21st Century Cures Act for the progression of interoperability
- The future use cases of interoperability, including advancing personalized medicine
For more from Dr. Rizk, read his article in MedCity News on how COVID-19 has highlighted the urgency of interoperability.